Streetbeat News

Legal

ALRM

Alarm.com Holdings, Inc. (NASDAQ:ALRM) shares rose in after-hours trading following the announcement of a resolution to its litigation with Vivint, which includes a long-term intellectual property license agreement. The stock has seen over a 20% increase since early November, partly due to strong third-quarter earnings. After-hours, ALRM shares were up 1.98% at $64.46.

Portfolio Pulse from Ryan Gustafson

December 28, 2023 | 11:29 pm

TCRT

Alaunos Therapeutics has entered into a separation and release agreement with CEO Kevin Boyle regarding his termination, according to a filing. Additionally, Boyle will enter into a consulting agreement with the company starting January 1, 2024, for a period of six months, to provide strategic and advisory services.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 9:39 pm

RGS

Regis Corporation has announced its intention to appeal the New York Stock Exchange's decision to begin delisting proceedings for the company's common stock. The appeal process will delay the delisting, but the outcome remains uncertain.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 9:08 pm

ALRM

Alarm.com (ALRM) and Vivint have settled all outstanding litigation and have entered into a long-term intellectual property license agreement. Alarm.com will license its intellectual property portfolio to Vivint. No further details on the settlement have been disclosed, as per SEC rules.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 9:06 pm

AAPL

MASI

The U.S. International Trade Commission (ITC) banned certain Apple Watch models due to patent infringement on Masimo Corporation's blood oxygen-reading technology. The White House, with the power to reverse the ban, did not intervene, but a federal appeals court suspended the ban. Masimo CEO Joe Kiani, a Biden supporter and donor, is connected to President Biden, raising conflict of interest concerns. The case could force Apple to license the technology or find alternatives. The ban's suspension allows Apple to continue sales, which are significant for its revenue.

Portfolio Pulse from Chris Katje

December 28, 2023 | 8:30 pm

BNBUSD

India's Financial Intelligence Unit has issued notices to nine major offshore crypto exchanges, including Binance and KuCoin, for non-compliance with AML and CFT regulations. The FIU IND has requested the blocking of their URLs to prevent illegal operations in India. These platforms have not registered under the PMLA, which is mandatory for operating in India. This regulatory action indicates a tightening of cryptocurrency market regulations in India and could have significant implications for these platforms and their Indian user base.

Portfolio Pulse from Murtuza Merchant

December 28, 2023 | 8:05 pm

NEO

NTRA

NVTA

NeoGenomics Inc (NEO) received a preliminary injunction from a North Carolina district court, prohibiting the sale of its RaDaR technology, following a lawsuit by Natera Inc (NTRA) alleging patent infringement. NeoGenomics plans to appeal the ruling. The injunction allows NeoGenomics to continue offering RaDaR for existing patients and certain projects. Earlier, Invitae Corporation (NVTA) faced a similar permanent injunction. Analysts from Needham and William Blair expressed concerns over the impact on NEO's growth narrative and stock sentiment. NEO's stock fell 18.60%, while NTRA's rose 2.58%.

Portfolio Pulse from Vandana Singh

December 28, 2023 | 5:57 pm

LOPE

Grand Canyon Education's stock is trading lower following a lawsuit by the FTC accusing the company of deceptive advertising and illegal telemarketing practices.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 5:50 pm

ASPN

CALT

CAN

CDT

CIFR

HUT

IREN

MARA

NEO

RIOT

UUUU

NeoGenomics, Inc. (NASDAQ:NEO) shares dropped 16.4% after losing a preliminary injunction in a patent lawsuit against its RaDar test. Other stocks also moved lower, including Calliditas Therapeutics, Wheels Up Experience, Hut 8 Corp, Iris Energy, Conduit Pharmaceuticals, Canaan Inc, Cipher Mining, Marathon Digital Holdings, Energy Fuels, Aspen Aerogels, and Riot Platforms, with various reasons such as FDA approvals, financial updates, and Bitcoin's pullback.

Portfolio Pulse from Avi Kapoor

December 28, 2023 | 3:53 pm

ALEAF

BUD

TCNNF

TLRY

The most-read cannabis stories of 2023 on Benzinga included a range of topics from the benefits of cannabis for aging brains, political shifts towards legalization, and high-profile celebrity endorsements. Key highlights include a study suggesting cannabis does not negatively impact cognition in older adults, Elon Musk's comments on psychoactive drugs, a man ditching morphine for marijuana to alleviate arthritis, Aleafia Health's expansion into Europe's medical cannabis market, a pathogen threatening California's cannabis crops, Florida's telehealth renewals for medical marijuana, GOP senators admitting legalization impacts drug cartels, Tilray's acquisition of beer brands from Anheuser-Busch, Snoop Dogg's anti-Trump TikTok video, Georgia's medical cannabis sales in pharmacies, and Ohio's GOP-led Senate approving expanded marijuana legislation.

Portfolio Pulse from Nina Zdinjak

December 28, 2023 | 2:54 pm